Brief: ProQR Therapeutics Q2 EPS EUR -0.08
13/08/2026 12:01
BRIEF-ProQR Therapeutics Q2 EPS EUR -0.08 Aug 13 (Reuters) - ProQR Therapeutics Q2 revenue EUR 8.759 million vs. IBES estimate EUR 4.58 million.
- Q2 basic EPS EUR -0.08
- Q2 net income EUR -8.728 million
- Q2 operating income EUR -8.822 million
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview